ArticleMedComm2026

Dynamic T-Cell Reprogramming Modulates the Treatment Outcome of Neoadjuvant Immunochemotherapy in Non-Small-Cell Lung Cancer.

Rui Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.